We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms. Genetic testing revealed that he carried a Brugada syndrome sodium channel SCN5A mutation (4189delT). This finding suggests that sotalol may be of therapeutic benefit in such patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amjcard.2004.02.023 | DOI Listing |
Publication Analysis
Top Keywords
brugada syndrome
12
effectiveness sotalol
4
sotalol treatment
4
treatment symptomatic
4
symptomatic brugada
4
syndrome describe
4
describe 53-year-old
4
53-year-old man
4
man recurrent
4
recurrent syncopal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!